Yuee Teng

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Binghe Xu, Qingyuan Zhang, Pin Zhang et al. · Nature Medicine · 2021 · 169 citations

Medicine, Oncology, Pharmacology +12

PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells

Dan Li, Xiujuan Qu, Kezuo Hou et al. · Anti-Cancer Drugs · 2008 · 158 citations

Life Sciences, Oncology, Pharmacology +17

Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation

Yu Shi, Chunlei Zheng, Yue Jin et al. · Frontiers in Oncology · 2020 · 149 citations · Full text

Medicine, Molecular Biology, Oncology +17

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial

Zefei Jiang, Quchang Ouyang, Tao Sun et al. · Nature Medicine · 2024 · 112 citations

Medicine, Oncology, Pharmacology +14

Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Pin Zhang, Qingyuan Zhang, Zhongsheng Tong et al. · The Lancet Oncology · 2023 · 95 citations

Medicine, Oncology, Pharmacology +16